Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Management / 管理學院
  3. Executive Master of Business Administration Program (EMBA) / 管理學院碩士在職專班 (EMBA)
  4. The Successful Model of Collaboration between Academia and Corporation for Medical Industry in Taiwan – Case study: Center for Innovative Therapeutics Discovery, National Taiwan University
 
  • Details

The Successful Model of Collaboration between Academia and Corporation for Medical Industry in Taiwan – Case study: Center for Innovative Therapeutics Discovery, National Taiwan University

Date Issued
2014
Date
2014
Author(s)
Wang, Ya-Chun
URI
http://ntur.lib.ntu.edu.tw//handle/246246/263623
Abstract
The collaboration and technical transfer between academic and industry are lack of successful case currently. Supposedly, the human capital, grants and resources invested from academic and RD institute should have the ability to provide a superior innovative new drug candidate for industry to develop in the second stage. This collaboration should help Taiwan’s biotech industry to stand out and meet the challenges in global market. The Center for Innovative Therapeutics Discovery (CITD), NTU has the vision, purpose and goal to establish the platform for long term development to be the bridge of new drug discovery and business development. The major tasks are two. First, CITD should establish the platform of core technology, core ability, core resources, and integration of resources for the discovery of innovative new drug. Second, CITD should be the bridge of academic and industry to establish the core technology and resources based on the needs of industry in Taiwan. How to screen the new drug leading compounds and train the professional skills for industry to use in the second stage should be the most important direction of CITD to push and promotion. Based on the diseases and unmet clinical needs evaluation, CITD could establish the core technology, ability, and resource on the fields with the challenging strength and professional skill in Taiwan, not the fields of big pharmaceutical company’s focus. For example, the live diseases HBV, HCC are the major problem for Chinese to be treated. CITD can create a standardized model for the collaboration of academic and industry to become the successful model meeting the needs of industry on Taiwan based on its unique RD structure, strategies, and core technology.
Subjects
產學合作
新藥產業
創新藥物
學術界研發成果
研發管理及激勵
SDGs

[SDGs]SDG3

Type
thesis
File(s)
Loading...
Thumbnail Image
Name

ntu-103-P00748031-1.pdf

Size

23.32 KB

Format

Adobe PDF

Checksum

(MD5):611fb954aa206318755f1249a9c1b744

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science